advertisement

Topcon

Fandino A 74

Showing records 1 to 25 | Display all abstracts from Fandino A

100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Tomar AS
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Tomar AS
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Tomar AS
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Tomar AS
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Finger PT
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Finger PT
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Gallie B
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Gallie B; Gallie B
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Gallie B; Kivelä TT
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Kivelä TT; Mallipatna A; Mallipatna A
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Mallipatna A; Mallipatna A; Zhang C
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Zhang C
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Zhao J
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Zhao J; Wilson MW
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Wilson MW; Wilson MW
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Wilson MW; Brennan RC; Brennan RC
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Brennan RC; Brennan RC; Burges M; Burges M
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Burges M; Burges M
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Kim J
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Kim J; Berry JL
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Berry JL; Berry JL
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Berry JL; Jubran R; Jubran R
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Jubran R; Jubran R; Khetan V
Ophthalmology 2022; 129: 933-945
100343 High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study
Khetan V; Ganesan S
Ophthalmology 2022; 129: 923-932
100467 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study
Ganesan S; Ganesan S
Ophthalmology 2022; 129: 933-945

Issue 23-1

Change Issue


advertisement

Oculus